Cargando…
Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
INTRODUCTION: Difference in clinical responses to cancer therapy in each patient is from several factors. Gastrointestinal microbiota is one of the reasons. However, this correlation remains unknown. This study aims to explore correlation between gastrointestinal microbiota profile and clinical outc...
Autores principales: | Saifon, Woraseth, Sensorn, Insee, Trachu, Narumol, Oranratnachai, Songporn, Charoenyingwattana, Angkana, Runcharoen, Chakkaphan, Monnamo, Nanamon, Sukkasem, Warawut, Inchareon, Pimpin, Suwatanapongched, Thitiporn, Chansriwong, Phichai, Ativitavas, Touch, Panvichian, Ravat, Chantratita, Wasun, Reungwetwattana, Thanyanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454126/ https://www.ncbi.nlm.nih.gov/pubmed/36076157 http://dx.doi.org/10.1186/s12885-022-10050-3 |
Ejemplares similares
-
Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients
por: Khiewngam, Khantong, et al.
Publicado: (2023) -
Role of BIM Deletion Polymorphism and BIM Expression as Predictive Biomarkers to Maximize the Benefit of EGFR-TKI Treatment in EGFR-Positive NSCLC
por: Incharoen, Pimpin, et al.
Publicado: (2019) -
CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients
por: Majam, Teerapat, et al.
Publicado: (2023) -
Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis
por: Oranratnachai, Songporn, et al.
Publicado: (2021) -
Host genetic polymorphisms involved in long-term symptoms of COVID-19
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2023)